<code id='A9BCD08BC2'></code><style id='A9BCD08BC2'></style>
    • <acronym id='A9BCD08BC2'></acronym>
      <center id='A9BCD08BC2'><center id='A9BCD08BC2'><tfoot id='A9BCD08BC2'></tfoot></center><abbr id='A9BCD08BC2'><dir id='A9BCD08BC2'><tfoot id='A9BCD08BC2'></tfoot><noframes id='A9BCD08BC2'>

    • <optgroup id='A9BCD08BC2'><strike id='A9BCD08BC2'><sup id='A9BCD08BC2'></sup></strike><code id='A9BCD08BC2'></code></optgroup>
        1. <b id='A9BCD08BC2'><label id='A9BCD08BC2'><select id='A9BCD08BC2'><dt id='A9BCD08BC2'><span id='A9BCD08BC2'></span></dt></select></label></b><u id='A9BCD08BC2'></u>
          <i id='A9BCD08BC2'><strike id='A9BCD08BC2'><tt id='A9BCD08BC2'><pre id='A9BCD08BC2'></pre></tt></strike></i>

          Home / hotspot / explore

          explore


          explore

          author:entertainment    Page View:4
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In